Latest Mass Tort News and Updates
$26B National Opioid Settlement Finalized
A $26 billion national opioid settlement involving drugmaker Johnson & Johnson and three major distributors has been finalized, and the funds would soon be consigned to every state and local…
Washington Would Get Additional $113 million in Purdue Pharma Settlement
The state of Washington would get an additional $113 million from Purdue Pharma and the Sackler family over the company and family's role in the opioid crisis across the…
3M Appeals The First Trial Loss
$483M From $26B National Opioid Settlement For Kentucky
Kentucky has reached a settlement of $483 million from the $26 billion national opioid settlement with a drugmaker and three major drug distributors of the U.S.
Current…
$6B Opioid Deal Between State Attorneys & Purdue
A group of attorneys has struck a $6 billion deal with the Sackler family, who is the owners of Purdue Pharma LP, over widespread litigation fueling the opioid epidemic.
…Talc Suit Documents Reveal J&J Conducted Awful Experiments
A famous American dermatologist conducted awful experiments from 1951 to 1974, like injecting the African American prisoners with asbestos and…
18M To New Hanover County In National Opioid Settlement
New Hanover County was the first North Carolina County that sued major pharmaceutical manufacturers and distributors over their roles in fueling the nationwide opioid crisis.
The overdose rate…
JPML Asked To Centralize Belviq Cancer Lawsuits
On Monday, a petition was filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML), requesting consolidation of Belviq cancer claims filed by the former users of the…
Legal Updates Center
Articles
Some in-depth and valuable articles for legal and medical professions.
Drugs Updates
Some in-depth and valuable articles for legal and medical professions.
Newsletter Legal Updates
Here you can read the most recent Mass Torts and Personal Injury News.
Medical Devices
Get the latest updates related to medical devices like 3M earplugs, Hernia Mesh, Etc.